Cardiovascular disease (CVD) is responsible for up to 25% of premature deaths in the UK, 80% of which are preventable. We explore the role integrated care systems could play in scaling up the ...

Research indicates that lifestyle choices significantly outweigh genetic predispositions in determining health outcomes. A ...

The European Society of Cardiology (ESC) welcomes the European Commission's presentation on 16 July of the proposal for the Multiannual Financial ...

And when you’re experiencing unusual symptoms, it’s often hard to tell whether to head straight to the hospital or deal with ...

The Trump administration is doing damage control on the visible signs of aging in the president, as seen in his swollen legs ...

Baxdrostat meets primary and all secondary endpoints in BaxHTN phase III trial in patients with uncontrolled or treatment resistant hypertension: Cambridge, UK Wednesday, July 16, ...

White House officials announced on July 17 that president Donald Trump was diagnosed with chronic venous insufficiency. What is CVI?

Treating coronary artery disease patients with monotherapy using clopidogrel or ticagrelor was associated with lower rates of ...

AstraZeneca announced that baxdrostat, a selective aldosterone synthase inhibitor, met its primary and all secondary endpoints in the BaxHTN Phase III trial, effectively lowering blood pressure ...

AstraZeneca said on Monday its experimental drug baxdrostat significantly lowered blood pressure in a late-stage trial of ...

Respiratory syncytial virus (RSV) infections were associated with significantly increased risk for complications beyond ...